Angiogenesis & therapeutic targets in cancer /:
Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs t...
Gespeichert in:
Weitere Verfasser: | , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
[Place of publication not identified] :
Bentham e Books,
[2010]
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs that target antiangiogenic cascade in different forms of cancers like breast cancer, multiple myeloma, renal carcinoma, gastrointestinal, prostate and lung cancer. Surrogate predictive markers of antiangiogenic therapy in novel preclinical models recapitulating tumor microenvironment together with ge. |
Beschreibung: | 1 online resource (viii, 225 pages) |
Bibliographie: | Includes bibliographical references and index. |
ISBN: | 9781608050079 1608050076 |
Internformat
MARC
LEADER | 00000cam a2200000Ma 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocn708569306 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 080523s2010 xx ob 001 0 eng d | ||
040 | |a E7B |b eng |e pn |c E7B |d OCLCQ |d EBLCP |d MHW |d OCLCQ |d OCLCO |d OCLCQ |d N$T |d OCLCF |d OCLCQ |d BENTH |d OCLCQ |d AU@ |d OCLCQ |d YDXCP |d DEBSZ |d OCLCQ |d AZK |d AGLDB |d ICA |d MOR |d PIFAG |d ZCU |d MERUC |d OCLCQ |d U3W |d D6H |d OCLCQ |d STF |d WRM |d VTS |d ICG |d VT2 |d OCLCQ |d WYU |d TKN |d DKC |d OCLCQ |d HS0 |d OCLCQ |d UKAHL |d AJS |d OCLCO |d QGK |d S2H |d OCLCQ |d OCLCO | ||
019 | |a 774507721 |a 842262230 |a 961563151 |a 962680897 |a 1058455140 |a 1259205466 |a 1289517942 | ||
020 | |a 9781608050079 |q (electronic bk.) | ||
020 | |a 1608050076 |q (electronic bk.) | ||
024 | 3 | |a 9781608050079 | |
035 | |a (OCoLC)708569306 |z (OCoLC)774507721 |z (OCoLC)842262230 |z (OCoLC)961563151 |z (OCoLC)962680897 |z (OCoLC)1058455140 |z (OCoLC)1259205466 |z (OCoLC)1289517942 | ||
037 | |b 01479942 | ||
050 | 4 | |a RC271.N46 |b A54 2010eb | |
072 | 7 | |a SCI |x 003000 |2 bisacsh | |
072 | 7 | |a TEC |x 057000 |2 bisacsh | |
072 | 7 | |a TEC |x 035000 |2 bisacsh | |
082 | 7 | |a 600 | |
049 | |a MAIN | ||
245 | 0 | 0 | |a Angiogenesis & therapeutic targets in cancer / |c editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana. |
260 | |a [Place of publication not identified] : |b Bentham e Books, |c [2010] | ||
300 | |a 1 online resource (viii, 225 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file |2 rda | ||
504 | |a Includes bibliographical references and index. | ||
520 | |a Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs that target antiangiogenic cascade in different forms of cancers like breast cancer, multiple myeloma, renal carcinoma, gastrointestinal, prostate and lung cancer. Surrogate predictive markers of antiangiogenic therapy in novel preclinical models recapitulating tumor microenvironment together with ge. | ||
588 | 0 | |a Print version record. | |
505 | 0 | |a 01 Title.pdf; 02 Cover Page and Dedication; 03 eBooks End User License Agreement-Website; 05 Foreword; 06 Preface; 08 CONTRIBUTORS; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Chapter 04; 13 Chapter 05; 14 Chapter 06; 15 Chapter 07; 16 Chapter 08; 17 Chapter 09; 18 Chapter 10; 19 Chapter 11; 21 Chapter 13; 22 INDEX_final_3 | |
546 | |a English. | ||
650 | 0 | |a Neovascularization inhibitors. |0 http://id.loc.gov/authorities/subjects/sh93004625 | |
650 | 0 | |a Cancer |x Treatment. |0 http://id.loc.gov/authorities/subjects/sh85019547 | |
650 | 2 | |a Angiogenesis Inhibitors |0 https://id.nlm.nih.gov/mesh/D020533 | |
650 | 6 | |a Néovascularisation |x Inhibiteurs. | |
650 | 6 | |a Cancer |x Traitement. | |
650 | 7 | |a SCIENCE |x Applied Sciences. |2 bisacsh | |
650 | 7 | |a TECHNOLOGY & ENGINEERING |x Inventions. |2 bisacsh | |
650 | 7 | |a TECHNOLOGY & ENGINEERING |x Reference. |2 bisacsh | |
650 | 7 | |a Cancer |x Treatment |2 fast | |
650 | 7 | |a Neovascularization inhibitors |2 fast | |
700 | 1 | |a Chatterjee, Malay. | |
700 | 1 | |a Rana, Ajay. | |
700 | 1 | |a Rana, Basabi. | |
776 | 1 | |z 1-60805-573-6 | |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500751 |3 Volltext |
938 | |a Askews and Holts Library Services |b ASKH |n AH37537099 | ||
938 | |a Bentham Science Publisher |b BENT |n 9781608050079 | ||
938 | |a EBL - Ebook Library |b EBLB |n EBL864193 | ||
938 | |a ebrary |b EBRY |n ebr10447986 | ||
938 | |a EBSCOhost |b EBSC |n 500751 | ||
938 | |a YBP Library Services |b YANK |n 3628841 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocn708569306 |
---|---|
_version_ | 1816881754442563584 |
adam_text | |
any_adam_object | |
author2 | Chatterjee, Malay Rana, Ajay Rana, Basabi |
author2_role | |
author2_variant | m c mc a r ar b r br |
author_facet | Chatterjee, Malay Rana, Ajay Rana, Basabi |
author_sort | Chatterjee, Malay |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RC271 |
callnumber-raw | RC271.N46 A54 2010eb |
callnumber-search | RC271.N46 A54 2010eb |
callnumber-sort | RC 3271 N46 A54 42010EB |
callnumber-subject | RC - Internal Medicine |
collection | ZDB-4-EBA |
contents | 01 Title.pdf; 02 Cover Page and Dedication; 03 eBooks End User License Agreement-Website; 05 Foreword; 06 Preface; 08 CONTRIBUTORS; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Chapter 04; 13 Chapter 05; 14 Chapter 06; 15 Chapter 07; 16 Chapter 08; 17 Chapter 09; 18 Chapter 10; 19 Chapter 11; 21 Chapter 13; 22 INDEX_final_3 |
ctrlnum | (OCoLC)708569306 |
dewey-full | 600 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 600 - Technology (Applied sciences) |
dewey-raw | 600 |
dewey-search | 600 |
dewey-sort | 3600 |
dewey-tens | 600 - Technology (Applied sciences) |
discipline | Technik allgemein |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03805cam a2200661Ma 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn708569306</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">080523s2010 xx ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">E7B</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">MHW</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">BENTH</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">AGLDB</subfield><subfield code="d">ICA</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">U3W</subfield><subfield code="d">D6H</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">STF</subfield><subfield code="d">WRM</subfield><subfield code="d">VTS</subfield><subfield code="d">ICG</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">TKN</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">HS0</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKAHL</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">QGK</subfield><subfield code="d">S2H</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">774507721</subfield><subfield code="a">842262230</subfield><subfield code="a">961563151</subfield><subfield code="a">962680897</subfield><subfield code="a">1058455140</subfield><subfield code="a">1259205466</subfield><subfield code="a">1289517942</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781608050079</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1608050076</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9781608050079</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)708569306</subfield><subfield code="z">(OCoLC)774507721</subfield><subfield code="z">(OCoLC)842262230</subfield><subfield code="z">(OCoLC)961563151</subfield><subfield code="z">(OCoLC)962680897</subfield><subfield code="z">(OCoLC)1058455140</subfield><subfield code="z">(OCoLC)1259205466</subfield><subfield code="z">(OCoLC)1289517942</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="b">01479942</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC271.N46</subfield><subfield code="b">A54 2010eb</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SCI</subfield><subfield code="x">003000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TEC</subfield><subfield code="x">057000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">TEC</subfield><subfield code="x">035000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">600</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Angiogenesis & therapeutic targets in cancer /</subfield><subfield code="c">editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">Bentham e Books,</subfield><subfield code="c">[2010]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (viii, 225 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">data file</subfield><subfield code="2">rda</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs that target antiangiogenic cascade in different forms of cancers like breast cancer, multiple myeloma, renal carcinoma, gastrointestinal, prostate and lung cancer. Surrogate predictive markers of antiangiogenic therapy in novel preclinical models recapitulating tumor microenvironment together with ge.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">01 Title.pdf; 02 Cover Page and Dedication; 03 eBooks End User License Agreement-Website; 05 Foreword; 06 Preface; 08 CONTRIBUTORS; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Chapter 04; 13 Chapter 05; 14 Chapter 06; 15 Chapter 07; 16 Chapter 08; 17 Chapter 09; 18 Chapter 10; 19 Chapter 11; 21 Chapter 13; 22 INDEX_final_3</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Neovascularization inhibitors.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh93004625</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85019547</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Angiogenesis Inhibitors</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D020533</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Néovascularisation</subfield><subfield code="x">Inhibiteurs.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Cancer</subfield><subfield code="x">Traitement.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SCIENCE</subfield><subfield code="x">Applied Sciences.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING</subfield><subfield code="x">Inventions.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING</subfield><subfield code="x">Reference.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neovascularization inhibitors</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chatterjee, Malay.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rana, Ajay.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rana, Basabi.</subfield></datafield><datafield tag="776" ind1="1" ind2=" "><subfield code="z">1-60805-573-6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500751</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH37537099</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Bentham Science Publisher</subfield><subfield code="b">BENT</subfield><subfield code="n">9781608050079</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL864193</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10447986</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">500751</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3628841</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-ocn708569306 |
illustrated | Not Illustrated |
indexdate | 2024-11-27T13:17:45Z |
institution | BVB |
isbn | 9781608050079 1608050076 |
language | English |
oclc_num | 708569306 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource (viii, 225 pages) |
psigel | ZDB-4-EBA |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Bentham e Books, |
record_format | marc |
spelling | Angiogenesis & therapeutic targets in cancer / editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana. [Place of publication not identified] : Bentham e Books, [2010] 1 online resource (viii, 225 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier data file rda Includes bibliographical references and index. Angiogenesis plays rate limiting roles in tumor growth and invasion. Angiogenesis inhibition has been proposed as a general strategy to fight against cancers. This book covers different therapeutic targets for angiogenesis interventions with emphasis on clinical development of antiangiogenic drugs that target antiangiogenic cascade in different forms of cancers like breast cancer, multiple myeloma, renal carcinoma, gastrointestinal, prostate and lung cancer. Surrogate predictive markers of antiangiogenic therapy in novel preclinical models recapitulating tumor microenvironment together with ge. Print version record. 01 Title.pdf; 02 Cover Page and Dedication; 03 eBooks End User License Agreement-Website; 05 Foreword; 06 Preface; 08 CONTRIBUTORS; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Chapter 04; 13 Chapter 05; 14 Chapter 06; 15 Chapter 07; 16 Chapter 08; 17 Chapter 09; 18 Chapter 10; 19 Chapter 11; 21 Chapter 13; 22 INDEX_final_3 English. Neovascularization inhibitors. http://id.loc.gov/authorities/subjects/sh93004625 Cancer Treatment. http://id.loc.gov/authorities/subjects/sh85019547 Angiogenesis Inhibitors https://id.nlm.nih.gov/mesh/D020533 Néovascularisation Inhibiteurs. Cancer Traitement. SCIENCE Applied Sciences. bisacsh TECHNOLOGY & ENGINEERING Inventions. bisacsh TECHNOLOGY & ENGINEERING Reference. bisacsh Cancer Treatment fast Neovascularization inhibitors fast Chatterjee, Malay. Rana, Ajay. Rana, Basabi. 1-60805-573-6 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500751 Volltext |
spellingShingle | Angiogenesis & therapeutic targets in cancer / 01 Title.pdf; 02 Cover Page and Dedication; 03 eBooks End User License Agreement-Website; 05 Foreword; 06 Preface; 08 CONTRIBUTORS; 09 Chapter 01; 10 Chapter 02; 11 Chapter 03; 12 Chapter 04; 13 Chapter 05; 14 Chapter 06; 15 Chapter 07; 16 Chapter 08; 17 Chapter 09; 18 Chapter 10; 19 Chapter 11; 21 Chapter 13; 22 INDEX_final_3 Neovascularization inhibitors. http://id.loc.gov/authorities/subjects/sh93004625 Cancer Treatment. http://id.loc.gov/authorities/subjects/sh85019547 Angiogenesis Inhibitors https://id.nlm.nih.gov/mesh/D020533 Néovascularisation Inhibiteurs. Cancer Traitement. SCIENCE Applied Sciences. bisacsh TECHNOLOGY & ENGINEERING Inventions. bisacsh TECHNOLOGY & ENGINEERING Reference. bisacsh Cancer Treatment fast Neovascularization inhibitors fast |
subject_GND | http://id.loc.gov/authorities/subjects/sh93004625 http://id.loc.gov/authorities/subjects/sh85019547 https://id.nlm.nih.gov/mesh/D020533 |
title | Angiogenesis & therapeutic targets in cancer / |
title_auth | Angiogenesis & therapeutic targets in cancer / |
title_exact_search | Angiogenesis & therapeutic targets in cancer / |
title_full | Angiogenesis & therapeutic targets in cancer / editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana. |
title_fullStr | Angiogenesis & therapeutic targets in cancer / editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana. |
title_full_unstemmed | Angiogenesis & therapeutic targets in cancer / editor, Malay Chatterjee ; co-editors, Ajay Rana, Basabi Rana. |
title_short | Angiogenesis & therapeutic targets in cancer / |
title_sort | angiogenesis therapeutic targets in cancer |
topic | Neovascularization inhibitors. http://id.loc.gov/authorities/subjects/sh93004625 Cancer Treatment. http://id.loc.gov/authorities/subjects/sh85019547 Angiogenesis Inhibitors https://id.nlm.nih.gov/mesh/D020533 Néovascularisation Inhibiteurs. Cancer Traitement. SCIENCE Applied Sciences. bisacsh TECHNOLOGY & ENGINEERING Inventions. bisacsh TECHNOLOGY & ENGINEERING Reference. bisacsh Cancer Treatment fast Neovascularization inhibitors fast |
topic_facet | Neovascularization inhibitors. Cancer Treatment. Angiogenesis Inhibitors Néovascularisation Inhibiteurs. Cancer Traitement. SCIENCE Applied Sciences. TECHNOLOGY & ENGINEERING Inventions. TECHNOLOGY & ENGINEERING Reference. Cancer Treatment Neovascularization inhibitors |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=500751 |
work_keys_str_mv | AT chatterjeemalay angiogenesistherapeutictargetsincancer AT ranaajay angiogenesistherapeutictargetsincancer AT ranabasabi angiogenesistherapeutictargetsincancer |